AksharDataGet in touch
Menu

Molecular and disease cohorts

Genomics, pathology and oncology data for focused cohorts

Develop a brief that connects assay, specimen, diagnosis and clinical timeline. This category spans molecular diagnostics, digital pathology, disease cohorts and documented treatment outcomes.

Dataset scope

Typical contents and formats

Potential deliverables include VCF or panel tables, whole-slide image formats, structured clinical tables and manifests describing tissue handling and specimen linkage.

Commercial and research applications

Commercial applications

Commercial applications may include authorized diagnostic evaluation, study planning and biomarker or therapy development.

Research applications

Matched cohorts can support molecular characterization or outcome studies. Define index treatment, response criteria, censoring and minimum observation requirements before comparing datasets.

Due diligence

What to review before licensing

Data quality

Assess sequencing depth, panel version, tissue preservation, scanner settings, slide coverage and consistency of staging. Document exclusions and missing follow-up.

Licensing and delivery

Clarify rights for each data modality and linked outcome. Define permitted analyses, publication, derived outputs and access controls for sensitive data.

Governance

Genetic information can remain sensitive after direct identifiers are removed. Review consent scope, institutional permissions, linkage risk and restrictions on sharing or cross-border processing.

How to start sourcing

Specify disease and subtype, assay or slide modality, cohort volume, follow-up and what specimen-level linkage is required.

See the sourcing process

Common questions

Frequently asked questions

Can pathology images be paired with molecular data?

Pairing depends on source linkage, specimen identity and authorization for combined use. Request a linkage inventory and completeness figures before agreeing scope.

How should I describe an oncology outcome dataset?

Specify line of treatment, outcome definition, timing, censoring and source of verification. State which variables must be present for each record.

Related data categories

Source or buy data

Share business contact details and non-sensitive aggregate information. Keep records, credentials and raw datasets out of this form.

Online inquiry submission is temporarily unavailable. Use the email shown on the Contact page.

Include business context and aggregate details only.
Add optional qualification details
Use countries or regions, separated by commas.
Give an aggregate count and unit, such as 50,000 studies.
For example, CSV, Parquet or DICOM.
Include currency and whether it is approved.

We use your information to review and reply to your inquiry. This form uses Google reCAPTCHA. See our Privacy Policy.

License or sell data

Share business contact details and non-sensitive aggregate information. Keep records, credentials and raw datasets out of this form.

Online inquiry submission is temporarily unavailable. Use the email shown on the Contact page.

Include business context and aggregate details only.
Add optional qualification details
Give an aggregate count and unit, such as 50,000 studies.
Use countries or regions, separated by commas.
For example, CSV, Parquet or DICOM.

We use your information to review and reply to your inquiry. This form uses Google reCAPTCHA. See our Privacy Policy.

Privacy choices

Optional analytics help us measure which pages and inquiry forms people use. You can change your choice here anytime.